Skip to main content
. 2022 Jun 21;2022(6):CD006404. doi: 10.1002/14651858.CD006404.pub4

3.3. Analysis.

3.3

Comparison 3: Pyronaridine‐artesunate versus mefloquine plus artesunate, Outcome 3: Total failure: day 28 (unadjusted)